ZimVie to Present at the UBS Global Healthcare Conference

ZIMV 10.29.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-12
Name of Upcoming Event:UBS Global Healthcare Conference
Full Press ReleaseSEC FilingsOur ZIMV Tweets

About Gravity Analytica

Recent News

  • 11.12.2024 - UBS Global Healthcare Conference
  • 10.30.2024 - ZimVie to Report Third Quarter 2024 Financial Results
  • 10.30.2024 - ZimVie Reports Third Quarter 2024 Financial Results

Recent Filings

  • 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
  • 10.30.2024 - EX-99.1 EX-99.1

PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.

A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website atinvestor.zimvie.com.

About ZimVieZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us atwww.ZimVie.com. Follow @ZimVie onTwitter,Facebook,LinkedIn, orInstagram.

Media Contact Information:

ZimVieGrace Flowers •Grace.Flowers@ZimVie.com(561) 319-6130

Investor Contact Information:

Gilmartin Group LLCMarissa Bych •Marissa@gilmartinir.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com